Masahiko Miyagi

411 total citations
15 papers, 321 citations indexed

About

Masahiko Miyagi is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Masahiko Miyagi has authored 15 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Masahiko Miyagi's work include Diabetes Treatment and Management (9 papers), Diabetes Management and Research (6 papers) and Pancreatic function and diabetes (4 papers). Masahiko Miyagi is often cited by papers focused on Diabetes Treatment and Management (9 papers), Diabetes Management and Research (6 papers) and Pancreatic function and diabetes (4 papers). Masahiko Miyagi collaborates with scholars based in Japan. Masahiko Miyagi's co-authors include Hiroshi Uchino, Takahisa Hirose, Naoki Kumashiro, Fumika Shigiyama, Eiichiro Kanda, Yukio Ando, Yuka Kobayashi, Hiroshi Yoshino, Naoki Hiroi and Mariko Sue and has published in prestigious journals such as The Lancet Infectious Diseases, Diabetes Obesity and Metabolism and Diabetes Research and Clinical Practice.

In The Last Decade

Masahiko Miyagi

15 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masahiko Miyagi Japan 6 244 100 87 75 37 15 321
Surya Panicker Rajeev United Kingdom 7 232 1.0× 108 1.1× 107 1.2× 29 0.4× 49 1.3× 14 285
Başak Karbek Türkiye 13 262 1.1× 32 0.3× 74 0.9× 68 0.9× 48 1.3× 22 438
Katelee Barrett Mueller United States 5 270 1.1× 84 0.8× 174 2.0× 162 2.2× 56 1.5× 5 418
Fumika Shigiyama Japan 9 354 1.5× 159 1.6× 132 1.5× 121 1.6× 70 1.9× 18 506
Yoko Matsuzawa Japan 11 242 1.0× 77 0.8× 192 2.2× 39 0.5× 50 1.4× 33 409
Elisa P. Jensen Denmark 8 258 1.1× 89 0.9× 159 1.8× 26 0.3× 48 1.3× 10 322
Armando Puocci Italy 6 130 0.5× 76 0.8× 59 0.7× 48 0.6× 52 1.4× 6 229
Martina Franzese Italy 6 130 0.5× 76 0.8× 59 0.7× 48 0.6× 52 1.4× 6 229
Ada Pesapane Italy 7 132 0.5× 77 0.8× 60 0.7× 48 0.6× 58 1.6× 9 238
Benjamin Assad Jaghutriz Germany 8 226 0.9× 97 1.0× 156 1.8× 68 0.9× 87 2.4× 12 410

Countries citing papers authored by Masahiko Miyagi

Since Specialization
Citations

This map shows the geographic impact of Masahiko Miyagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiko Miyagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiko Miyagi more than expected).

Fields of papers citing papers by Masahiko Miyagi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahiko Miyagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiko Miyagi. The network helps show where Masahiko Miyagi may publish in the future.

Co-authorship network of co-authors of Masahiko Miyagi

This figure shows the co-authorship network connecting the top 25 collaborators of Masahiko Miyagi. A scholar is included among the top collaborators of Masahiko Miyagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiko Miyagi. Masahiko Miyagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Uchino, Hiroshi, et al.. (2023). SGLT2 inhibitor versus carbohydrate-restricted isocaloric diet: reprogramming substrate oxidation in type 2 diabetes. Diabetology & Metabolic Syndrome. 15(1). 25–25. 1 indexed citations
3.
Uchino, Hiroshi, Masahiko Miyagi, Kazutoshi Isobe, et al.. (2021). Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan. Diabetes Metabolic Syndrome and Obesity. Volume 14. 773–781. 6 indexed citations
4.
5.
Kumashiro, Naoki, Fumika Shigiyama, Masahiko Miyagi, et al.. (2021). Changes in subjective sleep quality in patients with type 2 diabetes who did not use Sleep agents: a cross-sectional study according to age and clinical background. Diabetology International. 13(1). 142–147. 2 indexed citations
6.
Shigiyama, Fumika, Yukio Ando, Masahiko Miyagi, et al.. (2020). Chronotherapeutic efficacy of suvorexant on sleep quality and metabolic parameters in patients with type 2 diabetes and insomnia. Diabetes Research and Clinical Practice. 169. 108412–108412. 15 indexed citations
7.
8.
9.
10.
Kumashiro, Naoki, Fumika Shigiyama, Hiroshi Uchino, et al.. (2018). Efficacy of intermittent empagliflozin supplementation on dietary self‐management and glycaemic control in patients with poorly controlled type 2 diabetes: A 24‐week randomized controlled trial. Diabetes Obesity and Metabolism. 21(2). 303–311. 2 indexed citations
11.
Uchino, Hiroshi, Masahiko Miyagi, Naoki Kumashiro, et al.. (2017). Glycemic Variability in Type 1 Diabetes Compared with Degludec and Glargine on the Morning Injection: An Open-label Randomized Controlled Trial. Diabetes Therapy. 8(4). 783–792. 26 indexed citations
12.
Shigiyama, Fumika, Naoki Kumashiro, Masahiko Miyagi, et al.. (2017). Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study. Cardiovascular Diabetology. 16(1). 84–84. 199 indexed citations
13.
Shigiyama, Fumika, Naoki Kumashiro, Masahiko Miyagi, et al.. (2016). Linagliptin improves endothelial function in patients with type 2 diabetes: A randomized study of linagliptin effectiveness on endothelial function. Journal of Diabetes Investigation. 8(3). 330–340. 35 indexed citations
14.
Uchino, Hiroshi, et al.. (2014). Acute focal bacterial nephritis in an occupational allergy. The Lancet Infectious Diseases. 14(7). 656–656. 3 indexed citations
15.
Hiroi, Naoki, et al.. (2011). Thyroid storm associated with Graves' disease covered by diabetic ketoacidosis: A case report. Thyroid Research. 4(1). 8–8. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Surya Panicker Rajeev Breakdown of academic impact, for papers by Başak Karbek Breakdown of academic impact, for papers by Katelee Barrett Mueller Breakdown of academic impact, for papers by Fumika Shigiyama Breakdown of academic impact, for papers by Yoko Matsuzawa Breakdown of academic impact, for papers by Elisa P. Jensen Breakdown of academic impact, for papers by Armando Puocci Breakdown of academic impact, for papers by Martina Franzese Breakdown of academic impact, for papers by Ada Pesapane Breakdown of academic impact, for papers by Benjamin Assad Jaghutriz
Rankless by CCL
2026